300-08-3 | Arecoline hydrobromide

Packsize	Purity	Availability	Price	Discounted Price
100mg	95%	in stock	$25.00	$18.00
1g	95%	in stock	$26.00	$18.00
5g	95%	in stock	$50.00	$35.00
10g	95%	in stock	$82.00	$58.00
25g	95%	in stock	$155.00	$108.00
100g	95%	in stock	$511.00	$358.00

Description

• Catalog Number: AB45571
• Chemical Name: Arecoline hydrobromide
• CAS Number: 300-08-3
• Molecular Formula: C8H14BrNO2
• Molecular Weight: 236.1063
• MDL Number: MFCD00039041
• SMILES: COC(=O)C1=CCCN(C1)C.Br

Computed Properties

• Complexity: 187
• Covalently-Bonded Unit Count: 2
• Heavy Atom Count: 12
• Hydrogen Bond Acceptor Count: 3
• Hydrogen Bond Donor Count: 1
• Rotatable Bond Count: 2

Upstream Synthesis Route

3-Pyridinecarboxylicacid, 1,2,5,6-tetrahydro-1-methyl-, methyl ester, hydrobromide is a versatile compound used in various chemical synthesis processes. Its unique chemical structure makes it a valuable component in the synthesis of pharmaceuticals, agrochemicals, and specialty chemicals.In chemical synthesis, this compound is commonly employed as a key intermediate in the production of complex organic molecules. It serves as a building block for constructing different molecular frameworks through a series of synthetic steps. Its hydrobromide form ensures stability and ease of handling in reactions, making it a preferred choice in the synthesis of diverse chemical compounds.Furthermore, the methyl ester group in this compound plays a crucial role in facilitating various chemical transformations, such as esterification, amidation, and hydrogenation reactions. This functionality enhances the compound's reactivity and enables precise control over the synthesis process, leading to high purity and yield of the desired products.Overall, 3-Pyridinecarboxylicacid, 1,2,5,6-tetrahydro-1-methyl-, methyl ester, hydrobromide is a valuable tool in chemical synthesis, enabling the efficient and scalable production of a wide range of chemical compounds with diverse applications.

Literature

• Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.

  Bioorganic & medicinal chemistry 20121115

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Discovering selective agonists of endothelial target for acetylcholine (ETA) via diversity-guided pharmacophore simplification and simulation.

  Bioorganic & medicinal chemistry letters 20040621

• Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase.

  Journal of natural products 19910101